Use of a New Method for the Microbiological Diagnosis of Severe Corneal Infection
NCT05888987 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 46
Last updated 2024-09-19
Summary
Microbial keratitis is a severe and often blindness-inducing pathology which represents today the first reason for long-term hospitalization (more than 5 days) in ophthalmology. Its diagnosis is clinical and leads to an immediate hospitalization in the presence of serious criteria (Mackie classification). The entire process of microbiological diagnosis requires several days before etiological confirmation and therefore delays the initiation of targeted therapy.
Recently, new PCR systems allowing the detection of 18 to 27 pathogens in 75 minutes have been developed. Their use could thus be transposed to ophthalmology by adapting the microbiological diagnostic technique to samples currently taken by swabbing the cornea.
The investigators will compare their diagnosis performance versus conventional methods on patients who suffered for a microbial keratitis with severity criteria.
Conditions
- Infectious Keratitis
- Microbial Keratitis
- Corneal Infection
Interventions
- BIOLOGICAL
-
PCR multiplex by FilmArray
PCR multiplex by FilmArray system on corneal swabbing sample
Sponsors & Collaborators
-
CHU de Reims
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-07-07
- Primary Completion
- 2027-01-07
- Completion
- 2027-08-07
Countries
- France
Study Locations
More Related Trials
-
The Ocular Microbiome in Patients With Dry Eye Disease
NCT04656197 ·Status: COMPLETED
-
Ocular Surface Microbiome
NCT02298881 ·Status: COMPLETED
-
Correlation of Different Signs for Assessment of Dry Eye Syndrome
NCT01753687 ·Status: COMPLETED ·Phase: NA
-
Ocular Surface Dry Eye Microbiome
NCT02306668 ·Status: UNKNOWN
-
Change in Ocular Flora Resistance From Repeated Topical Antibiotic Use
NCT01181713 ·Status: COMPLETED
-
Lenticule Implantation and Autologous Serum New Approach in Treatment of Adenoviral Keratitis Disease
NCT05123014 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Are Corneal Epithelial Defects Related to Changes in Ocular Bacterial Flora in Patients With ANLDO
NCT02234700 ·Status: UNKNOWN
-
Moxifloxacin AF Ophthalmic Solution for Treatment of Bacterial Conjunctivitis
NCT00759148 ·Status: COMPLETED ·Phase: PHASE3
-
Ocular Surface Immune Response in Dry Eye Disease
NCT02042820 ·Status: COMPLETED
-
An Evaluation of the Onset and Duration of Action of AKF-1 Ophthalmic Solution in Treating Acute Allergic Conjunctivitis
NCT01561521 ·Status: COMPLETED ·Phase: PHASE3
-
Ozone-based Eye Drops as Adjuvant Therapy in Microbial Keratitis
NCT05689996 ·Status: UNKNOWN ·Phase: PHASE3
-
An Open Label Comparing the Short Term Efficacy of Lacrisert
NCT03079271 ·Status: UNKNOWN ·Phase: PHASE4
-
Swiss PACK-CXL Multicenter Trial for the Treatment of Infectious Keratitis
NCT02717871 ·Status: COMPLETED ·Phase: PHASE3
-
Ocular Microbiome and Immune System in Dry Eyes
NCT04658238 ·Status: RECRUITING
-
Mycotic Antimicrobial Localized Injection for Treatment of Corneal Ulcers
NCT02731638 ·Status: COMPLETED ·Phase: PHASE3
-
Matrix Therapy And Bacterial Keratitis
NCT02016989 ·Status: UNKNOWN ·Phase: NA
-
Multimodal Screening of Dry Eye Disease
NCT04235400 ·Status: UNKNOWN
-
Evaluating Patients With Eye Allergies and Determining if There Are Also Dry Eyes
NCT01679015 ·Status: COMPLETED
-
Topical Interferon Alfa 2b and Mitomycin C in Conjunctival-Corneal Intraepithelial Neoplasia
NCT02199327 ·Status: COMPLETED ·Phase: PHASE4
-
Lid Margin And Conjunctival Microbial Flora Following Punctum Occlusion
NCT00735865 ·Status: COMPLETED ·Phase: NA
-
Evaluation and Treatment of Patients With Corneal and External Diseases
NCT00008541 ·Status: COMPLETED
-
Investigator-initiated Clinical Trial to Observe Conjunctival Goblet Cell Using an Anterior Segment Imaging Device
NCT06427629 ·Status: RECRUITING ·Phase: NA
-
Investigating Epstein-Barr Virus Associated Conjunctivitis
NCT06689397 ·Status: ENROLLING_BY_INVITATION
-
Combination Treatment of 5% Natamycin and 1% Voriconazole in Fungal Keratitis
NCT03230058 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Tear Film SARS-nCoV-2 Detection in Symptomatic and Pauci-symptomatic Patients.
NCT04799704 ·Status: TERMINATED